glp-1 home monitoring tools Semaglutide Symptoms & Outcomes Abbott CEO: GLP-1 Concerns in

What Regulators Say After extensive review, regulatory agencies have concluded: No confirmed causal link between GLP-1 medications and anger or aggression No black box warnings related to mood Continued monitoring is appropriate This reflects a balanced interpretation of available evidencenot dismissal of patient experiences, but also not overstating risk

What Are Incretins and the Incretin Effect

Compliance was good (93%) with no differences between PLC and MO groups

Common Semaglutide Compounded Formulations Compounded semaglutide is often marketed under names that mimic brand drugs, such as semaglutide with B12 or semaglutide sodium. These compounded formulations are not FDA-approved, and many lack safety testing and quality control

doi: 10.1016/j.metop.2024.100283 22 WildingJPHBatterhamRLDaviesMVan GaalLFKandlerKKonakliKet al